master's at Medical biotechnology from golestan university of medical science (2018). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Therapy with T-CAR cells against hematological neoplasm antigens, such as CAR-T anti CD19, has shown excellent remission rates. However, this type of CAR-T cell therapy is limited by the availability of tumor-specific surface antigens, sparing normal cells. There is a rich diversity of intracellularly expressed tumor protein antigens that current and conventional CAR-T cells are unable to…
Chimeric antigen receptor (CAR)-cell based therapies has emerged as a promising strategy in the field of cancer treatment. Natural killer (NK) cells are innate immune cells with the ability to exert rapid cytotoxicity against transformed and virus-infected cells without prior sensitization and in an HLA-unrestricted manner, which makes it a suitable candidate for "off-the-shelf" cancer im…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID